Sandra Levy
ARTICLES BY THIS AUTHOR
- 4/19/2020
FDA gives tentative nod for Alembic's generic Lastacaft
Alcaftadine ophthalmic solution has a market value of roughly $7 million for the 12 months ended December 2019, according to IQVIA. - 4/19/2020
NCPA survey finds majority of local pharmacies need small business federal aid
An NCPA survey found that 85% of independent pharmacies are reporting an increase in the number of products reimbursed below acquisition cost since March 1. - 4/19/2020
CVS Health expands rapid COVID-19 drive-through testing sites to Connecticut
CVS Health, now has COVID-19 drive-through testing sites in four states: Georgia, Massachusetts, Rhode Island, and Connecticut. - 4/19/2020
Zydus Cadila gets FDA OK for Baclofen
Zydus Cadila's baclofen tablets are available in a dosage strength of 5 mg. - 4/16/2020
Zydus gets tentative OK for generic Opsumit
Generic Opsumit tablets will be available in a dosage strength of 10 mg. - 4/16/2020
NACDS hits airwaves to thank pharmacists, push for bigger pharmacy role in COVID-19 response
NACDS has conducted 39 broadcast interviews thanking pharmacy teams and urging the government to remove barriers for pharmacists to respond to COVID-19. - 4/15/2020
Mylan's Robert Coury returns as executive chairman
Robert Coury returns to Mylan as executive chairman amid the COVID-19 outbreak, and activities needed to close the combination of Mylan and Upjohn. - 4/15/2020
NACDS shares state-level public opinion on pharmacies and COVID-19
Seventy-six percent of voters agree that COVID-19 has shown that public health partners like pharmacies are important and that barriers need to be removed. - 4/15/2020
Amneal launches generic Butrans
Butrans had a market value of roughly $225 million for the 12 months ended February 2020, according to IQVIA. - 4/15/2020
NCPA survey finds pharmacists facing drug shortages amid pandemic
Local pharmacists are reporting shortages of albuterol inhalers, hydroxychloroquine, azithromycin, and other drugs in high demand since the COVID-19 outbreak, according to a new survey from NCPA.
